Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01190631 · ClinicalTrials.gov registry record · NA

An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation

A NA study, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT01190631: Completed NA study, sponsored by Alcon Research.

NCT01190631 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01190631, a NA study, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study was to evaluate total residual spherical aberration (TSA) post-IOL implantation, and to determine if an association exists between TSA, postoperative high order aberrations (HOA), and functional vision following IOL implantation in patients grouped by pre-operative corneal spherical aberration (CSA).

Primary Outcome

Contrast sensitivity is the measurement of one's ability to detect slight changes in luminance before it becomes indistinguishable. It is measured in logarithmic units by means of an illuminated box, the CSV 1000 by Vector Vision. A higher value for the logarithmic units translates to better contrast sensitivity.

Interventions

  • DEVICE Acrysof IQ (SN60WF) IOL

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-07
Phase NA
Alcon Research

275 total trials

What the finished NCT01190631 record still lists

NCT01190631 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Acrysof IQ (SN60WF) IOL is the first listed.

NCT01190631 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01190631 about?

NCT01190631 is a clinical study titled "An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation". The purpose of this study was to evaluate total residual spherical aberration (TSA) post-IOL implantation, and to determine if an association exists between TSA, postoperative high order aberrations (HOA), and functional vision following IOL implantation in patients grouped by pre-operative corneal ...

What is the current status of trial NCT01190631?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-07.

What interventions are being tested in trial NCT01190631?

The interventions under investigation include: Acrysof IQ (SN60WF) IOL (DEVICE).

Who is sponsoring clinical trial NCT01190631?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01190631's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01190631, the US trial registry maintained by the National Library of Medicine. NCT01190631 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.